Remove the Obstacles to Device Innovation
Over the past several months, there has been a large focus on the American medical device industry and regulatory approval and…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2011
American Research and Competitiveness Act of 2010
Medical device and pharmaceutical companies face significant regulatory and legal obstacles in developing new and life-saving…
Pooled CME Funding a May Be a Road to No Where
Medical societies and other providers have been under assault the last few years for the way they handle commercial funds for…
Archives of Internal Medicine: Clinical Practice Guidelines No Harm But Ban…
As science continues to advance and medical discoveries persistently make our lives healthier and better, a number of critics are…
Physician Payment Sunshine: GSK Reports Research Payments
Following the steps of the vast majority of large pharmaceutical companies, GlaxoSmithKline (GSK) recently published a list of…
Physician Payment Sunshine: Pfizer Reports $177 million in Payments to…
Pfizer Inc. released a report detailing the company’s financial interactions with health care professionals and researchers in…
JAMA Disclosure of Interests in Meta Analyses
A recent article from the Journal of the American Medical Association (JAMA) noted that, “disclosure of conflicts of interest…
FDA Regulations Doubles Review Time and Quadruples Trial Size for Diabetes…
Cardiovascular safety issues with a number of drugs led the Food and Drug Administration (FDA) in late 2008 to introduce new…
IOM Clinical Practice Guidelines We Can Trust — But What About the…
The Institute of Medicine (IOM) issued two reports last week “that it said will provide an objective and consistent framework for…
FDA Budget: Trying to Do Everything on Less Money
Recently, the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration…